CS
SRTA

Clear Street’s Strata Critical Medical Inc SRTA Stock Holding History

Clear Street’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-52,174
Closed -$251K – 1115
2025
Q4 		$251K Hold
52,174
– – ﹤0.01% 432
2025
Q3 		$264K Buy
+52,174
New +$230K ﹤0.01% 336

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Clear Street's SRTA Position: Q1 2026 in Review

Clear Street sold out of Strata Critical Medical Inc (SRTA) in Q1 2026, closing a stake of 52,174 shares — an estimated $251K sold.

Clear Street first reported a position in SRTA in Q3 2025 and held it in 2 quarters. The position peaked at $264K in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Clear Street reported no remaining Strata Critical Medical Inc position as of Q1 2026 after selling out during the quarter.
  • Clear Street sold 52,174 Strata Critical Medical Inc shares in Q1 2026, an estimated $251K.
  • Clear Street first reported a position in Strata Critical Medical Inc in Q3 2025 and held it in 2 quarters.
  • Clear Street's Strata Critical Medical Inc position peaked at $264K in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.